Survodutide
A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and With
Boehringer Ingelheim · Phase 1 · Completed · Enrollment 82
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Part A: BI 456906: Cohort 1 | Obesity or overweight | n/r | 28 | n/r | n/r |
| Part A: BI 456906: Cohort 2 | Obesity or overweight | n/r | 28 | n/r | n/r |
| Part A: BI 456906: Cohort 3 | Obesity or overweight | n/r | 28 | n/r | n/r |
| Part A: BI 456906: Cohort 4 | Obesity or overweight | n/r | 28 | n/r | n/r |
| Part B: BI456906: Cohort 1 | Obesity or overweight | n/r | 28 | n/r | n/r |
| Part B: BI456906: Cohort 2 | Obesity or overweight | n/r | 28 | n/r | n/r |
| Part B: BI456906: Cohort 3 | Obesity or overweight | n/r | 28 | n/r | n/r |